Leflox®

  • All Products
  • By Generic
  • By Therapeutic Segment

Leflox®

Therapeutic Segment: Antibiotic

Generic Name: Levofloxacin

Indication:

For the treatment of adults ( ≥ 18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in below conditions:

  • Nosocomial Pneumonia – indicated for the treatment of nosocomial pneumonia due to methicillin susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, or Streptococcus pneumoniae.
  • Community-Acquired Pneumonia: 7–14 Day Treatment Regimen.
    Indicated for the treatment of community-acquired pneumonia due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (including multidrug-resistant Streptococcus pneumoniae [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae.
  • Acute bacterial sinusitis; Acute exacerbation of chronic bronchitis; Typhoid and paratyphoid fever; Complicated & Uncomplicated skin & skin structure infections; Chronic bacterial prostitis; Complicated & uncomplicated urinary tract Infections (mild to moderate); Acute pyelonephritis.

Available as:

Injectable
  • 500MG/100ML
Tablets
  • 500MG